Therapeutic Asset Ratings
308 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Dp Cd8 Til
Melanoma
AgonOx, Inc.
P1
C
(37)
dxc014
Melanoma
Hangzhou DAC Biotechnology Co., Ltd.
P1
C
(37)
Emunkitug
Melanoma
HiFiBiO Therapeutics
P1
C
(37)
Etakafusp Alfa
Melanoma
Asher Biotherapeutics, Inc.
P1
C
(37)
Exarafenib
Melanoma
Pierre Fabre Medicament
P1
C
(37)
Ezabenlimab
Melanoma
Boehringer Ingelheim
P1
C
(37)
FLUDEOXYGLUCOSE
Melanoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
P1
C
(37)
FUROSEMIDE
Melanoma
M.D. Anderson Cancer Center
P1
C
(37)
hfb200603
Melanoma
HiFiBiO Therapeutics
P1
C
(37)
H-gamma1 heavy chain humanized (1-449) [VH (Homo sapiens IGHV3-23*01 (81.6%) -(IGHD) -IGHJ3*02 (91.7%) M123>T (114), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sapiens IGHG1*03v (100%) G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (216) (120-217), hinge 1-15 (218-232), CH2 (233-342), CH3 E12 (358), M14 (360) (343-447), CHS (448-449)) (120-449)], (222-218')-disulfide with L-kappa light chain humanized (1'-218') [VKAPPA (Homo sapiens IGKV1-33*01 (87.8%) -IGKJ4*01 (100%), CDR-IMGT [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo sapiens IGKC*01 (100%) Km3 A45.1, V101 (C-KAPPAA45.1 (157'), V101 (195')) (112'-218')]; dimer (228-228'':231-231'')-bisdisulfide, produced in Chinese hamster ovary (CHO) cells, cell line CHO-K1, glycoform alfa
Melanoma
Genentech, Inc.
P1
C
(37)
hlx17
Melanoma
Shanghai Henlius Biotech
P1
C
(37)
hlx18
Melanoma
Shanghai Henlius Biotech
P1
C
(37)
Idov-Immune
Melanoma
ViroMissile, Inc.
P1
C
(37)
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
Melanoma
Toray Industries, Inc
P1
C
(37)
immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF4 (tumor necrosis factor receptor (TNFR) superfamily member 4, OX40, CD134)], Homo sapiens monoclonal antibody
Melanoma
HiFiBiO Therapeutics
P1
C
(37)
Ivonescimab
Melanoma
Peking University Cancer Hospital & Institute
P1
C
(37)
Jsi-1187
Melanoma
JS InnoPharm, LLC
P1
C
(37)
lm103
Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
P1
C
(37)
ln-144
Melanoma
James Isaacs, MD
P1
C
(37)
Loperamide
Melanoma
M.D. Anderson Cancer Center
P1
C
(37)
lyl845
Melanoma
Lyell Immunopharma, Inc.
P1
C
(37)
mb097
Melanoma
Microbiotica Ltd
P1
C
(37)
Mem-288 Intratumoral
Melanoma
Memgen, Inc.
P1
C
(37)
MGC026
Melanoma
MacroGenics
P1
C
(37)
Modified Vaccinia Virus Ankara Vaccine Expressing P53
Melanoma
City of Hope Medical Center
P1
C
(37)
Showing 226 to 250 of 308 assets
Previous
Page 10 of 13
Next
